Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALLKristina Müller, Denis M. Schewe, Lennart Lenk et al.|Blood|2022Cited by 47
Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosisFotini Vogiatzi, Denis M. Schewe, Julia Heymann et al.|Blood Advances|2022Cited by 20